Department of Biological Sciences

Permanent URI for this communityhttp://itsupport.cu.edu.ng:4000/handle/123456789/28749

Welcome to the Department of Biological Sciences

Browse

Subject: search.filters.subject.Gut microbiome

Search Results

Now showing 1 - 2 of 2
  • No Thumbnail Available
    Item
    CHARACTERIZATION OF THE GUT MICROBIOME AND INFLAMMATORY MARKERS IN TREATMENT-NAIVE TRIPLE-NEGATIVE BREAST CANCER (TNBC) PATIENTS IN LAGOS, NIGERIA
    (Covenant University Ota, 2025-10) OGUNLEYE, Oluwanifemi Omodara; Covenant University Dissertation
    Triple-negative breast cancer (TNBC) is an aggressive subtype lacking estrogen, progesterone, and HER2 receptors. Emerging studies suggest that gut microbial imbalance and chronic inflammation may contribute to breast cancer progression. This study investigated the gut microbiome profile and circulating inflammatory markers in treatment-naive TNBC patients compared with unknown subtypes and healthy controls to understand the microbiome–inflammation relationship in TNBC pathogenesis. Fecal DNA from TNBC, unknown subtype, and healthy control groups was extracted and analyzed using 16S rRNA sequencing through the Nephele QIIME2 pipeline. Alpha diversity was evaluated with the Shannon index, and group differences were tested using the Kruskal–Wallis and Mann–Whitney tests. Serum IL-6 and TNF-α levels were quantified using ELISA, and correlations were assessed using Pearson and Spearman analyses. Alpha diversity analysis revealed no statistically significant difference among groups (Kruskal–Wallis p = 0.298), though TNBC samples exhibited lower and more variable Shannon index values compared with controls. TNBC samples showed unstable high levels of Firmicutes, and Bacteriodota, and varying low levels of Proteobacteria and Actinobacteriota, indicating microbial imbalance. IL-6 and TNF-α levels did not differ significantly between TNBC and controls (p > 0.05), though TNBC patients displayed higher variability. A moderate positive correlation was found between IL-6 and TNF-α in TNBC (r = 0.5982), indicating co-regulated inflammatory activity. The PICRUSt functional prediction revealed altered microbial metabolic pathways in TNBC patients compared to controls, particularly a reduction in butyrate and propionate metabolism associated with short-chain fatty acid production. The findings suggest early gut dysbiosis and immune imbalance in TNBC despite the absence of significant statistical differences. Reduced microbial diversity, altered phylum-level composition, and cytokine co-regulation indicate biological perturbations in treatment-naive TNBC. These findings collectively support a potential link between microbial dysbiosis, altered short-chain fatty acid metabolism and elevated inflammatory activity in TNBC pathogenesis. It also highlights the need for larger, longitudinal studies to validate microbial and inflammatory biomarkers for early disease characterization.
  • No Thumbnail Available
    Item
    CHARACTERISATION OF THE GUT MICROBIOME AND FUNCTIONAL PROFILE IN ESTROGEN RECEPTOR-POSITIVE BREAST CANCER PATIENTS IN LAGOS, NIGERIA
    (Covenant University Ota, 2025-10) WILLIAMS, Moyosoreoluwa Mary; Covenant University Dissertation
    Estrogen receptor-positive (ER+) breast cancer is the most prevalent molecular subtype globally, yet its association with gut microbial composition, functional potential and inflammatory drivers remains uncharacterised in sub-Saharan Africa. Employing the intersection of microbiology, oncology, and genomics, this study investigated the gut microbiome, predicted functional profiles, and systemic inflammatory markers in treatment-naïve ER+ breast cancer patients compared to healthy controls in Lagos, Nigeria. Faecal DNA samples from participants were extracted and analysed using 16S rRNA sequencing on the Illumina MiSeq platform using the QIIME2 pipeline. Microbial diversity was assessed through alpha (Shannon index) and beta diversity (NMDS, PCoA) metrics, and the group differences were tested using the Mann–Whitney test and Kruskal–Wallis, while PICRUSt2 predicted functional pathways with on focus on β-glucuronidase. Concurrently, systemic inflammation was evaluated through the quantification of Interleukin-6 (IL-6) and C-reactive protein (CRP) from blood serum. Analysis revealed no significant differences in alpha diversity between groups (p > 0.05). However, beta diversity demonstrated substantial compositional divergence (PERMANOVA R²=0.11, p=0.02), with cases showing an elevated Firmicutes/Bacteroidota ratio and depletion of Actinobacteriota, including Bifidobacterium and Collinsella. Functional prediction indicated heightened β-glucuronidase activity in ER+ cases, suggesting enhanced estrogen reactivation potential. Inflammatory markers displayed a complex profile, with significantly reduced IL-6 levels in patients despite stable CRP concentrations. These findings characterise distinct gut microbial dysbiosis and functional alterations in Nigerian ER+ breast cancer patients, revealing an estrobolome configuration potentially contributing to pathogenesis. The results underscore the necessity of population-specific microbiome studies and highlight potential biomarkers for early detection and targeted interventions in this understudied population.